Pre-commercialization of circadian clock-drug interactions screening tool for therapeutic applications

The CIRCOMMUNICATION project aims to commercialize CircaSCOPE, a high-throughput method for constructing Phase Transition Curves to enhance drug efficacy and minimize side effects through chronotherapy.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

Circadian clocks carry immense importance to human health, as clock disruption is related to various malignancies from sleep disorders through diabetes to cancer. Furthermore, many drug targets are influenced by circadian clocks. In order to maximize a drug’s efficacy while minimizing side effects, it is necessary to consider the drug’s time-of-administration, also known as “chronotherapy.” These revelations are critical for drug administration and development. However, their practical implementation is tempered by the lack of suitable research tools that bridge the gap from the bench to the clinic.

Phase Transition Curve (PTC)

The time-dependent effect of an intervention on the clock is represented by the Phase Transition Curve (PTC). PTC retrieval is laborious and challenging; consequently, they were mostly overlooked in the pharmaceutical R&D process.

CircaSCOPE Development

In the ERC Project CIRCOMMUNICATION, we studied clock-resetting mechanisms, which led to the development of CircaSCOPE, an efficient high-throughput methodology for high-resolution PTC construction.

Applications of CircaSCOPE

CircaSCOPE can be used as a powerful screening method for clock-modulating drugs, either for the purpose of:

  1. Targeting pathologies associated with circadian disruption, or
  2. Identifying drugs which elicit unwanted side effects on the clock.

Once fully developed and systematically integrated into chrono-medicine, CircaSCOPE has the potential to improve drug discovery and yield medicines with better therapeutic indices.

Commercialization Plan

Here, we detail our plan for the first steps toward the commercialization of our innovation. We will:

  • Demonstrate the applicability of this approach through drug library screens.
  • Expand the repertoire of cell types that the system relies on.
  • Explore different commercialization strategies and interact with potential stakeholders and end-users.

Given the medical importance of circadian effects, we envision that CircaSCOPE will become a gold-standard procedure in future drug development.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-4-2022
Einddatum30-9-2023
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • WEIZMANN INSTITUTE OF SCIENCEpenvoerder

Land(en)

Israel

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Circadian rhythm: from preclinical to post-diagnosis dementia

The RHYTHM IN DEMENTIA project aims to identify circadian rhythm features linked to dementia risk and progression, using accelerometry and biomarkers to inform prevention strategies.

€ 1.999.982
ERC ADG

Targeting the circadian clock in personalized disease prevention

This project aims to identify and mitigate health risks associated with disrupted circadian rhythms in night workers through genetic profiling and targeted interventions for healthier aging.

€ 2.499.965
ERC COG

The early ticking of the central circadian pacemaker: when and how

StarTicking aims to uncover the development and functionality of the circadian clock in mice and humans, linking early environmental factors to behavioral outcomes in pre-term infants.

€ 1.955.875
ERC STG

Co-option of host circadian rhythms in cancer

INN-TIME aims to uncover how tumors exploit circadian rhythms of innate immune and stromal cells to evade anti-tumoral defenses, paving the way for novel cancer therapies.

€ 1.500.000